• Home
  • About Us
    • Board of Directors
    • Advisory Board
    • Our Team
  • Our Science
    • Ionic Liquid Platform
    • Clinical Pipeline
  • Career
  • More
    • Clinical Trials
    • Press Releases
    • In the News
    • Publications
  • Contact Us
  • More
    • Home
    • About Us
      • Board of Directors
      • Advisory Board
      • Our Team
    • Our Science
      • Ionic Liquid Platform
      • Clinical Pipeline
    • Career
    • More
      • Clinical Trials
      • Press Releases
      • In the News
      • Publications
    • Contact Us
  • Home
  • About Us
    • Board of Directors
    • Advisory Board
    • Our Team
  • Our Science
    • Ionic Liquid Platform
    • Clinical Pipeline
  • Career
  • More
    • Clinical Trials
    • Press Releases
    • In the News
    • Publications
  • Contact Us

Contact Us

Have questions or want to connect? 

Send us a message or give us a call —

we’d love to hear from you!

Contact Us

Send us an Email

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CAGE Bio Inc.

CAGE Bio Inc. 733 Industrial Road San Carlos, CA 94070 US

Ph: +1 (501) 229-9458 Email: admin@cagebio.com

Join our mission to revolutionize skin health!

Careers

Copyright © 2020 CAGE Bio Inc. - All Rights Reserved.

  • Board of Directors
  • Our Team
  • Career
  • Contact Us

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept

Welcome! Check out our latest news.

 CAGE Bio Announces Phase 2b Trial for CGB-500 (1% Tofacitinib), a Breakthrough Topical JAK Inhibitor for Moderate to Severe Atopic Dermatitis

Learn more